<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Significant decrease of serum <z:chebi fb="1" ids="47775">high density lipoprotein cholesterol</z:chebi> (<z:chebi fb="0" ids="47775">HDL-C</z:chebi>) in cerebrovascular diseases (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) was mentioned in our previous report (1981) </plain></SENT>
<SENT sid="1" pm="."><plain>The results of further studies on <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> patterns of 425 cases of various <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> are presented </plain></SENT>
<SENT sid="2" pm="."><plain>Reduction of <z:chebi fb="17" ids="39025">HDL</z:chebi> level (including both <z:chebi fb="0" ids="47775">HDL-C</z:chebi> and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A1) was observed not only in the group of patients hospitalized due to <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> (<z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> or <z:mp ids='MP_0001914'>hemorrhage</z:mp>), but also in patients under <z:mpath ids='MPATH_458'>normal</z:mpath> living conditions </plain></SENT>
<SENT sid="3" pm="."><plain>The latter group included patients with <z:e sem="disease" ids="C0241832" disease_type="Disease or Syndrome" abbrv="">cerebrovascular insufficiency</z:e>, <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> mild residual neuro-muscular symptoms after recovery from <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>It is surmised that <z:chebi fb="17" ids="39025">HDL</z:chebi> lowering was present early in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> cases before attack of <z:e sem="disease" ids="C0038454" disease_type="Disease or Syndrome" abbrv="">apoplexy</z:e> and is one of the risk factors of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> The degree of <z:chebi fb="17" ids="39025">HDL</z:chebi> lowering in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> groups were much more marked than that in our reported cases of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (CHD) </plain></SENT>
<SENT sid="5" pm="."><plain>The prominent change of <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> pattern in CHD group was elevation of apoB and total cholesterol (TC); however, apoB and TC were approximately <z:mpath ids='MPATH_458'>normal</z:mpath> or significantly lower in certain <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> groups </plain></SENT>
</text></document>